Login / Signup

Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studies.

Santosh Kumar MauryaHoma FatmaAkhilesh Kumar MauryaNidhi MishraHifzur R Siddique
Published in: In silico pharmacology (2022)
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • epithelial mesenchymal transition
  • molecular docking
  • cell proliferation
  • transcription factor
  • case control
  • bone marrow
  • signaling pathway